Dr. Deepak Koppaka is one of the leading Consultant Medical Oncologists in Hyderabad with 8+ years of experience in the field of Oncology. He completed his MBBS from G.S.L. Medical College, Rajahmundry, in March 2011 and pursued MD in Radiation Oncology from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, December 2014. He also did DM in Medical Oncology from Kidwai Cancer Institute, Bangalore, July 2018.
Additionally, he is also a well-known member of the Association of Radiation Oncologists of India, European Society For Medical Oncology, American Society Of Clinical Oncology, Indian Society of Medical And Paediatric Oncology, and Indian Society of Oncology. Dr. Deepak Koppaka is also an expert in Chemotherapy and offers a variety of treatments like hormonal and biological therapies, immunotherapy, targeted therapy, etc. As a consultant medical oncologist, he worked at the American Oncology Institute, Hyderabad in a structural and interventional oncology section. Patients were provided with significant therapies for cancer, side effects of anti-cancer treatments, and cell malignancies in HIV AIDS patients.
He is trained in performing Central Line insertion, PICC insertion, Bone Marrow Aspiration and Biopsy, Lumbar Puncture, and Intrathecal Drug Administration. Further, he underwent dedicated training in treating and counselling patients receiving Systemic Therapies for Solid and Haematological Malignancies, performing Image-guided Tru-cut Biopsies, FNAC, Pleural, and Peritoneal Paracentesis, diagnosing and managing Medical and Oncological Emergencies.
Dr. Deepak Koppaka has done remarkable work in the field of oncology. Many of his works were published in medical journals. His authored chapters on Non-Small Cell Carcinoma Lung and Gemcitabine-Induced Supraventricular Tachycardia were read across the world. The digital editions of the articles can be found in the Clinical Cancer Investigation Journal, Indian Journal Of Medical And Paediatric Oncology, etc.
Currently, Dr. Deepak Koppaka is working at CARE Super Specialty Hospital, as the best Oncologist in Hyderabad. Language is not a barrier for him as he can speak Hindi, English and Telugu.
Treatment and Counselling Patients Receiving Systemic Therapies for Solid and Haematological Malignancies: Chemotherapy, Hormonal Therapies, Biological Therapies, Targeted Therapy, Immunotherapy
Prescribe and Administer Chemotherapy, Biological Therapy, Immunotherapy, Targeted Therapy
Diagnose and Manage Side Effects of Anti-cancer Treatments
Perform Central Line Insertion, PICC Line Insertion, Bone Marrow Aspiration and Biopsy, Lumbar Puncture and Intrathecal Drug Administration
Perform Image-guided Tru-cut Biopsies, FNACs, Pleural and Peritoneal Paracentesis
Diagnose and Manage Medical and Oncological Emergencies
Autologous Stem-cell Transplant for Hodgkin’s Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma
Induction and Consolidation Chemotherapies for ALL/AML
Management of Malignancies in Patients With HIV/AIDS
Participate and Contribute in a Multidisciplinary Clinic
Impact of Integration of Positron Emission Tomography-computer Tomography (PET-CT) in Radiotherapy Planning of Non-small Cell Carcinoma Lung (PGIMER) (Dissertation (M.D.)
Assessment and Comparison of CISNE Model Versus MASCC Model in Clinically Stable Febrile Neutropenia Patients. Kidwai Cancer Institute (Dissertation (D.M.)
Ex Vivoexpansion and Characterization of Circulating Non-small Cell Lung Cancer Cells for Individualized Drug Susceptibility Testing. Kidwai Cancer Institution, Institute of Bio-informatics (Project)
Concordance Between Clinically Relevant Targetable Mutations Detected on Tumor Tissue and Cell-free Tumor DNA Using Next-generation Sequencing in Non-small Cell Lung Cancer: a Prospective Study. Kidwai Cancer Institution, Indian Institute of Science (Project)
A Study of Recurrent / Metastatic Breast Cancer in Relation to Their Primary Subtype, Pattern of Recurrence and the Discordance Rate of Er, Pr and Her2. Kidwai Cancer Institute. (Project)
A Prospective Study to Determine the Clinical Characteristics and Response to Treatment in Double Expressor DLBCL Among All DLBCL Patients in a Tertiary Care Hospital in South India. Kidwai Cancer Institute (Project)
CXCR-4 Expression and Its Correlation With Clinical- Biological Characteristics in Patients With Acute Myeloid Leukemia. Kidwai Cancer Institute (Project)
A Prospective Study to Evaluate Pathological, Radiological Response, Toxicity Profile, and Pharmacoeconomics of Iap and Ap Regimens in Localized High-grade Osteosarcoma as Neoadjuvant Chemotherapy (Project)
Role of Pre-phase Treatment Prior to Definitive Chemotherapy in Patients With Diffuse Large B-cell Lymphoma (Project)
Articles1. Koppaka D, Kapoor R, Bahl A, Bansal A, Mittal BR, Et Al. (2015) Impact Of Integrating Pet-Ct In Radiotherapy Planning Of Non-Small Cell Carcinoma Lung: Dosimetric And Radiobiological Comparison. J Integr Oncol 4:139. Doi:10.4172/2329-6771.1000139.
Haleshappa RA, Koppaka D, Thanky AH, Padma M, Amirtham U, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Genito-Urinary Malignancies In Patients With Disorders Of Sexual Development: An Experience From A Regional Cancer Center.
Rudresha, A. H., Abhishek Anand, K. C. Lakshmaiah, K. Govind Babu, D. Lokanatha, Amirtham Usha, Linu Abraham Jacob, Suresh Babu, K. N. Lokesh, L. K. Rajeev, And Deepak Koppaka. 2017. ‘Clinicopathological Profile And Treatment Outcome Of Squamous Cell Carcinoma Breast At A Tertiary Cancer Center In South India’, Memo – Magazine Of European Medical Oncology, 10: 259-62.
Lakshmaiah, K. C., A. Anand, K. G. Babu, L. Dasappa, L. A. Jacob, M. C. S. Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, And D. Koppaka. 2017. ‘Role Of Taxanes In Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center In South India’, World J Oncol, 8: 110-16.
Jacob, Linu, Abhishek Anand, Kuntegowdanahalli Lakshmaiah, Govind Babu, Dasappa Lokanatha, M Suresh Babu, Kadabur Lokesh, Antapura Rudresha, L Rajeev, And Deepak Koppaka. 2018. ‘Clinicopathological Profile And Treatment Outcomes Of Bilateral Breast Cancer: A Study From Tertiary Cancer Center In South India’, Indian Journal Of Medical And Paediatric Oncology, 39: 58-61.
Lokanatha, D., A. Anand, K. C. Lakshmaiah, K. Govind Babu, L. A. Jacob, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Koppaka, And R. V. Kumar. 2017. ‘Primary Breast Angiosarcoma – A Single Institution Experience From A Tertiary Cancer Center In South India’, Breast Dis.
Kadabur, L., D. Koppaka, G. B. Kanakasetty, A. Usha, L. C. Kuntegowdanahalli, L. Dasappa, L. A. Jacob, S. Babu, R. A. Haleshappa, A. Abhishek, And L. K. Rajeev. 2017. ‘Dual Mutations And Complex Mutations In Metastatic Non-Small Cell Lung Cancer: A Single-Institution Experience From South India’, Indian J Cancer, 54: 228-30.
Lakshmaiah, K. C., Asati, V., Babu, K. G., Lokanath, D., Jacob, L. A., Babu, M. C., Lokesh, K. N., Rajeev, L. K., Rudresh, A. H., Saldanha, S., Koppaka, D., Patidar, R. And Premalata, C. S. (2018), Role Of Prephase Treatment Prior To Definitive Chemotherapy In Patients With Diffuse Large B‐Cell Lymphoma. Eur J Haematol.
Govind Babu K, Anand Abhishek, Lakshmaiah Kuntegowdanahalli C, Lokanatha Dasappa, Jacob Linu Abraham, Babu MC Suresh, Lokesh Kadabur N, Rudresha Haleshappa A, Rajeev Lakkavalli K, Saldanha Smitha C, Giri GV, Chethan R, Koppaka Deepak, Panwar Dipti And Kumar Rekha V (2018) Correlation Of BMI With Breast Cancer Subtype And Tumour Size. Ecancer 12 845.
Lokesh KN, Anand A, Lakshmaiah KC, Babu KG, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Panwar, D. Koppaka, R. Patidar. Clinical Profile And Treatment Outcomes Of Metastatic Neuroendocrine Carcinoma: A Single Institution Experience. South Asian J Cancer 2018;7:207-9.
Haleshappa RA, Koppaka D, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Pattern Of Malignancies In Patients With HIV-AIDS: A Single Institution Observational Study. JCSO 2018;16(4):E188-E192.©2018 Frontline Medical Communications. Doi: Https://Doi.Org/10.12788/Jcso.0416.
Babu KG, Patidar R, Kuntegowdanahalli CL, Dasappa L, Jacob LA, Babu S, AH Rudresha, KN Lokesh, LK Rajeev, Koppaka D, Asati V. Metastatic Synovial Sarcoma: Experience From A Tertiary Care Center From India. Indian J Med Paediatr Oncol 2018; XX:XX-XX.
Jacob LA, Asati V, Lakshmaiah KC, Govind B, Lokanatha D, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Mulchandani JN, Anand A, Koppaka D, Suma MN. Primary Cutaneous B-Cell Lymphoma: A Single-Center 5-Year Experience. Indian J Cancer 2017;XX:XX-XX. DOI: 10.4103/Ijc.IJC_418_17. 15.
Kanakasetty, G.B., Chethan, R., Lakshmaiah, K.C., Dasappa, L., Jacob, L.A., Babu, S., Lokesh, K.N., Haleshappa, R.A., Rajeev, L.K., Saldanha, S.C. And Deepak, K., 2019. Treatment Patterns And Comparative Analysis Of Non-Intensive Regimens In Elderly Acute Myeloid Leukemia Patients—A Real-World Experience From India. Annals Of Hematology, 98(4), Pp.881-888.
Balakrishnan, A., Koppaka, D., Anand, A., Deb, B., Grenci, G., Viasnoff, V., Thompson, E.W., Gowda, H., Bhat, R., Rangarajan, A. And Thiery, J.P., 2019. Circulating Tumor Cell Cluster Phenotype Allows Monitoring Response To Treatment And Predicts Survival. Scientific Reports, 9(1), P.7933.
Babu KG, D. Koppaka, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, Anand A , Vikas A, Chethan R , Vedam L. Detection Of Clinically Relevant Epidermal Growth Factor Receptor Pathway Mutations In Circulating Cell-Free Tumour DNA Using Next Generation Sequencing In Squamous Cell Carcinoma Lung. South Asian J Cancer 2018
Ali MA, Babaiah M, Mariappan P, Sinha S, Muralidhar KR, Ponaganti S, Shah PA, Vuba SP, Gorla AKR, Koppaka D. A Rare Case Of Recurrent Paget’s Disease Of The Vulva And Gluteal Region Treated With Radiation Therapy. Appl Rad Oncol. 2020;9(1):44-47 19.II. Abstracts 20.1. Jotwani AK, Jain R, Sharma V, Goud RS, Haranath R, Koppaka D, Mishra A, Komanduri SK, Chilukuri RP, Sangwan H. Development Of" Online Cancer Patient Assistance Pathway"(OCPAP) Technology Platform To Provide Treatment Guidance For Cancer Patients In Developing Countries.
BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM INDIA: PB1752. HemaSphere. 2019 Jun 1;3:805.
Rajegowda C, BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. CXCR-4 EXPRESSION AND ITS PROGNOSTIC IMPACT IN DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA: PB1704. HemaSphere. 2019 Jun 1;3:785.
Koppaka D, Kuntegowdanahalli LC, Lokanath D, Govind Babu K, Jacob LA, Suresh Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Smitha SC, Anand A. 421O Assessment And Comparison Of CISNE Model Versus MASCC Model In Clinically Stable Febrile Neutropenia Patients. Annals Of Oncology. 2018 Nov 1;29(Suppl_9):Mdy444-001.
Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ As A Patient-Derived Predictive Platform For Individualizing Treatment In Lung Cancer. Annals Of Oncology. 2018 Oct 1;29(Suppl_8):Mdy303-008.
Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ As A Patient-Derived Predictive Platform For Individualizing Treatment In Lung Cancer. Annals Of Oncology. 2018 Oct 1;29(Suppl_8): Mdy303-008.
Babu G, Koppaka D, Vl R. P2. 01-125 EGFR Mutations By NGS In Advanced Squamous Cell Lung Cancer. Journal Of Thoracic Oncology. 2018 Oct 1;13(10): S713. 27.8. Koppaka D, Lakshmaiah KC, Babu KG, Dasappa L, Jacob LA, Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Saldanha SC. 246P Clinical Profile And Outcomes Of Carcinoma Anal Canal: A Single Institution Experience. Annals Of Oncology. 2017 Nov 1;28(Suppl_10):Mdx660-053.
MBBS from G.S.L. Medical College, Rajahmundry in March 2011
MD (Radiation Oncology) From Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh in December 2014
DM (Medical Oncology) From Kidwai Cancer Institute, Bangalore in July 2018
Silver Medal (First Order) in MD Radiation Oncology at PGIMER, Chandigarh
Indian Society of Medical and Pediatric Oncology – Gold Medal (Best Outgoing Medical Oncology Postgraduate), 2018
Indian Society of Medical and Pediatric Oncology – Torrent Young Scholar Award, 2018 - First Prize
Indian Society of Medical and Pediatric Oncology - Torrent Young Scholar Award, 2018 - Best Orator Award
European Society for Medical Oncology (ESMO) Asia 2018 Congress – Merit Award
Quiz (National Level Competitions) - First Prize - 36th ICON (Indian Cooperative Oncology Network), March 2017
Quiz (National Level Competitions) - Second Prize - 37th ICON (Indian Cooperative Oncology Network), September 2017
Quiz (National Level Competitions) - First Prize - Innovation in Oncology-lung Cancer Edition, Indian Society of Oncology (ISO), April 2017
Quiz (National Level Competitions) - First Prize - 4th Sun's Platform for Education, Awareness & Knowledge (Speak), December 2017
Telugu, Hindi and English
Association Of Radiation Oncologists Of India
European Society For Medical Oncology
American Society Of Clinical Oncology
Indian Society Of Medical And Pediatric Oncology
Indian Society Of Oncology
If you cannot find answers to your queries, please fill out the enquiry form or call the number below. We will contact you shortly.